1Muirhead N, Baigman J, Burgess E, et al. Evidnce based recommendations for the clinical use of rHu EPO. Am J Kidney Dis, 1995,26 ( 2suppl 1 ): s1-s24.
2Radermacher J, Koch KM. Treatment of renal anemia by erythropoietin substitution. The effects on cardiovascular system. Clin Nephrol, 1995,44:S56- S 60.
3Neusser M, Tepel M, Zidek W. Erythropoietin increases cytosolic free calcium concentration in vascular smooth muscle cells. Cardiovasc Res 1993,27 (7): 1233-1236.
4Greavs SC, Gamble GD, Collins JF, et al. Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure. Am J Kidney Dis,1994,24(5) :768.
5Silberberg JS, Barre PE, Prichard SS, et al. Impact of left ventriclar hypertrophy on survival in end stage renal disease. Kidney Int, 1989,36 (2) :286-290.
6Pascoul J,Teruel JL,Mota JL,et al. Regression of left ventricular hypertrophy after partial correction of anemia with rHu EPO in patients on hemodialysis: a prospective study. Clin Nephrol, 1997,35:280-287.
7O Rourd RA, Hanrath P, Heng WN, et al. Report of the joint international society and federation of cardiology/World health Organization task force on echocardiograma. Circulation, 1984,69: 854A-857A.
8PortolesJ, Torralbo A, Martin P, et al. Cardiovascular effects of recombinant human erythropoietie ih predialysis patients. Am J Kidney Dis,1997,29(4) :541-548.
9Cannella G,Canna L,Sandrini M,et al. Reversal of left ventricular hypertrophy following rHu EPO treatment of anaemic dialysed uremic patients. Nephrol Dial Transplant, 1991,6( 1 ) :31-37.
10Washio M, Okuda S, Mizoue T, et al. Risk factors for left ventricular hypertrophy in chronic hemodialysis paitents. Clin Nephrol, 1997,47 (6):362.
2Talyor R,Manganaro L, OBrien J,et al.Impact of allogenic packed red blood cell transfusion on nosocomia linfection rates in the critcal ill patient[J].Critical Care Medicine,2002, 30:2249-2254.
3Sasaki R,Masuda S,Nagao M.Pleiotropic functions and tissue-specific expression of erythropoietin[J].News Physiol Sci,2001,16:110-113.
4VanL C,Gaillard C,Kraaijenhagen R, et al.Response of erythropoiesis and iron metabolism to recombin ant human erythropoietin in intensive care unit patients[J].Critical Care Medicine,2000,28:2773-2778.
